Company Filing History:
Years Active: 1996
Title: Maria Prat: Innovator in Hepatocyte Growth Factor Research
Introduction
Maria Prat is a notable inventor based in Turin, Italy. She has made significant contributions to the field of biotechnology, particularly in the study of hepatocyte growth factor (HGF) receptors. Her work has implications for various medical applications, showcasing her innovative spirit and dedication to research.
Latest Patents
Maria Prat holds a patent for "Truncated forms of the hepatocyte growth factor (HGF) receptor." This invention involves a protein that serves as an antagonist of hepatocyte growth factor. The protein is composed of two disulphide-linked chains of 50 kDa and either 75 or 85 kDa. The 5 kDa chain represents the alpha-chain of the tyrosine kinase encoded by the MET protooncogene, while the 75 or 85 kDa chain is a C-terminal truncated form of the beta-chain of the same tyrosine kinase. This patent highlights her innovative approach to addressing complex biological challenges.
Career Highlights
Maria Prat is associated with Farmitalia Carlo Erba S.r.l., where she continues to advance her research. Her work has garnered attention in the scientific community, and she is recognized for her contributions to understanding the mechanisms of HGF receptors.
Collaborations
Throughout her career, Maria has collaborated with esteemed colleagues such as Paolo Comoglio and Tiziana Crepaldi. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Maria Prat exemplifies the spirit of innovation in the field of biotechnology. Her patent on HGF receptors demonstrates her commitment to advancing medical science. Through her work and collaborations, she continues to make a significant impact in her field.